Eversept Partners, LP
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), Eversept Partners, LP reported 115 stock positions worth $1.8 billion. Its top holding was United Therapeutics (UTHR) at 8.5% of the portfolio, followed by Abivax SA-ADR (ABVX, 6.6%) and Encompass Health (EHC, 5.7%). Compared with Q1 2026, it opened 31 new positions, sold out of 20, added to 37 and reduced 40. The biggest buy was Ensign (ENSG, shares +3979%) and the biggest sale GSK PLC-Spon ADR (GSK, shares −73%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001697013
- Portfolio Value
- $1.8B (Q2 2026)
- SEC Filing
- 0001697013-26-000005 ↗ filed Aug 14, 2026
Holdings Value
Holdings 115 stocks · $1.8B
| UTHR United Therapeutics Corp. | 8.50% | 287,668 | $155.9M | Add +8.8% |
| ABVX Abivax SA-ADR | 6.64% | 913,880 | $121.8M | Reduce -2.2% |
| EHC Encompass Health Corp. | 5.66% | 1,026,919 | $103.8M | Add +429.1% |
| ENSG The Ensign Group Inc. | 5.26% | 602,079 | $96.5M | Add +3978.8% |
| VERA Vera Therapeutics Inc. | 5.18% | 2,212,770 | $94.9M | Add +1.8% |
| CLDX Celldex Therapeutics Inc. | 3.62% | 1,785,941 | $66.5M | Reduce -0.1% |
| SNDX Syndax Pharmaceuticals Inc. | 3.33% | 2,798,210 | $61.2M | Reduce -3.0% |
| BKD Brookdale Senior Living Inc. | 2.98% | 3,396,470 | $54.6M | Reduce -4.8% |
| IONS Ionis Pharmaceuticals Inc. | 2.87% | 664,684 | $52.7M | Add +5.2% |
| NTRA Natera Inc. | 2.60% | 175,807 | $47.7M | Reduce -54.3% |
| TVTX Travere Therapeutics Inc. | 2.47% | 798,973 | $45.4M | Add +47.3% |
| CTRE Caretrust REIT Inc. | 2.36% | 1,072,015 | $43.3M | New |
| HCA HCA Healthcare Inc. | 2.09% | 98,252 | $38.3M | Add +24.0% |
| PCVX Vaxcyte Inc. | 2.00% | 629,952 | $36.6M | Reduce -31.8% |
| LQDA Liquidia Corp. | 1.86% | 428,652 | $34.2M | Reduce -36.7% |
| CYH Community Health Systems Inc. | 1.43% | 7,864,575 | $26.3M | Reduce -9.4% |
| GSK GSK PLC-Spon ADR | 1.38% | 481,833 | $25.3M | Reduce -73.0% |
| CHE Chemed Corp. | 1.33% | 52,523 | $24.5M | Add +69.1% |
| LLY Eli Lilly & Co. | 1.32% | 20,116 | $24.1M | Add +5.9% |
| GERN Geron Corp. | 1.31% | 18,717,422 | $24.0M | Reduce -0.6% |
| VKTX Viking Therapeutics Inc. | 1.28% | 602,922 | $23.5M | Add +152.2% |
| OHI Omega Healthcare Investors | 1.26% | 483,547 | $23.1M | Reduce -17.4% |
| PODD Insulet Corp. | 1.24% | 148,816 | $22.7M | Add +3.7% |
| THC Tenet Healthcare Corp. | 1.16% | 114,199 | $21.4M | Add +287.0% |
| UNH Unitedhealth Group Inc. | 1.16% | 51,145 | $21.3M | New |
| WELL Welltower Inc. | 1.08% | 87,312 | $19.8M | Reduce -51.8% |
| BBNX Beta Bionics Inc. | 1.07% | 1,249,441 | $19.6M | Reduce -11.7% |
| COGT Cogent Biosciences Inc. | 1.03% | 490,235 | $19.0M | New |
| BCRX Biocryst Pharmaceuticals Inc. | 1.02% | 1,865,653 | $18.7M | Reduce -38.6% |
| MOH Molina Healthcare Inc. | 1.00% | 80,594 | $18.4M | Add +145.6% |
| PNTG The Pennant Group Inc. | 0.93% | 460,272 | $17.0M | Add +47.4% |
| LTC LTC Properties Inc. filed as LTC PPTYS INC | 0.88% | 420,640 | $16.2M | Add +31.0% |
| INSM Insmed Inc. | 0.87% | 149,209 | $15.9M | New |
| VRDN Viridian Therapeutics Inc. | 0.83% | 831,142 | $15.3M | Add +16.5% |
| BMRN Biomarin Pharmaceutical Inc. | 0.78% | 249,607 | $14.3M | Add +20.1% |
| AMN Amn Healthcare Services Inc. | 0.76% | 428,531 | $13.9M | New |
| CELC Celcuity Inc. | 0.73% | 127,931 | $13.4M | New |
| PHVS Pharvaris NV | 0.73% | 386,383 | $13.4M | Reduce -5.1% |
| CTMX Cytomx Therapeutics Inc. | 0.73% | 3,558,497 | $13.3M | Add +11.6% |
| HUM Humana Inc. | 0.68% | 31,171 | $12.4M | New |
| XENE Xenon Pharmaceuticals Inc. | 0.65% | 196,532 | $11.9M | Add +51.7% |
| CRVS Corvus Pharmaceuticals Inc. | 0.61% | 747,994 | $11.2M | New |
| ASND Ascendis Pharma A/S | 0.61% | 41,621 | $11.1M | New |
| BRKR Bruker Corp. | 0.60% | 182,894 | $11.0M | Add +56.3% |
| MRNA Moderna Inc. | 0.58% | 152,122 | $10.7M | Reduce -4.8% |
| GPCR Structure Therapeutics Inc. | 0.57% | 196,302 | $10.5M | Add +42.2% |
| DFTX Definium Therapeutics Inc. | 0.56% | 217,185 | $10.2M | Add +35.1% |
| CMPS Compass Pathways PLC | 0.52% | 672,825 | $9.5M | Reduce -0.8% |
| NAMS Newamsterdam Pharma Co. NV | 0.51% | 275,471 | $9.3M | Reduce -3.6% |
| RVTY Revvity Inc. | 0.51% | 83,624 | $9.3M | Reduce -1.4% |
| PALI Palisade Bio Inc. | 0.48% | 4,182,785 | $8.7M | Reduce -16.1% |
| ARDX Ardelyx Inc. | 0.47% | 1,678,345 | $8.6M | Reduce -24.7% |
| MLYS Mineralys Therapeutics Inc. | 0.46% | 309,689 | $8.4M | New |
| RLAY Relay Therapeutics Inc. | 0.44% | 434,314 | $8.1M | Add +60.4% |
| NVO Novo-Nordisk A/S-Spons ADR | 0.44% | 169,227 | $8.1M | New |
| BHVN Biohaven Ltd. | 0.42% | 515,804 | $7.7M | New |
| PTGX Protagonist Therapeutics Inc. | 0.39% | 58,504 | $7.2M | New |
| ELVN Enliven Therapeutics Inc. | 0.38% | 136,631 | $6.9M | New |
| REPL Replimune Group Inc. | 0.36% | 590,252 | $6.5M | Add +76.3% |
| LBRX LB Pharmaceuticals Inc. | 0.33% | 183,663 | $6.0M | Add +83.3% |
| BEAM Beam Therapeutics Inc. | 0.31% | 166,289 | $5.7M | New |
| NHI Natl Health Investors Inc. filed as NATIONAL HEALTH INVS INC | 0.29% | 70,673 | $5.4M | New |
| RARE Ultragenyx Pharmaceutical Inc. | 0.28% | 154,130 | $5.1M | Add +146.3% |
| PACS Pacs Group Inc. | 0.27% | 117,441 | $5.0M | New |
| EQ Equillium Inc. | 0.27% | 1,520,824 | $4.9M | Add +1.5% |
| ANAB Anaptysbio Inc. | 0.26% | 69,983 | $4.7M | Add +158.3% |
| NHC National Healthcare Corp. | 0.25% | 22,116 | $4.7M | New |
| EYPT Eyepoint Inc. | 0.23% | 297,735 | $4.3M | New |
| SNDA Sonida Senior Living Inc. | 0.23% | 102,624 | $4.2M | Add +260.9% |
| GKOS Glaukos Corp. | 0.22% | 29,343 | $4.1M | Reduce -51.3% |
| AGL Agilon Health Inc. | 0.22% | 37,792 | $4.1M | Reduce -78.6% |
| ARQT Arcutis Biotherapeutics Inc. | 0.19% | 135,355 | $3.5M | Reduce -76.5% |
| TARS Tarsus Pharmaceuticals Inc. | 0.19% | 55,710 | $3.5M | New |
| ANRO Alto Neuroscience Inc. | 0.18% | 128,286 | $3.4M | Add +2.5% |
| SPRY Ars Pharmaceuticals Inc. | 0.16% | 377,007 | $3.0M | Add +176.7% |
| IFRX Inflarx NV | 0.16% | 1,304,069 | $2.9M | Reduce -25.9% |
| ISRG Intuitive Surgical Inc. | 0.16% | 7,241 | $2.9M | Reduce -34.9% |
| ALEC Alector Inc. | 0.16% | 1,423,873 | $2.9M | Add +5.4% |
| VOR Vor Biopharma Inc. | 0.15% | 149,681 | $2.8M | New |
| DSGN Design Therapeutics Inc. | 0.15% | 190,000 | $2.7M | New |
| KPTI Karyopharm Therapeutics Inc. | 0.15% | 276,174 | $2.7M | No change |
| PMVP PMV Pharmaceuticals Inc. | 0.14% | 1,890,904 | $2.5M | Reduce -19.5% |
| CTNM Contineum Therapeutics Inc. Class A | 0.13% | 148,017 | $2.4M | Add +1.1% |
| EVMN Evommune Inc. | 0.13% | 174,460 | $2.3M | Add +219.1% |
| AMRN Amarin Corp. PLC -ADR | 0.13% | 145,296 | $2.3M | Reduce -1.6% |
| SPRB Spruce Biosciences Inc. | 0.12% | 40,000 | $2.2M | New |
| RGEN Repligen Corp. | 0.11% | 14,401 | $2.0M | Reduce -88.1% |
| IVVD Invivyd Inc. | 0.11% | 2,237,015 | $2.0M | Reduce -1.7% |
| PRQR Proqr Therapeutics NV | 0.10% | 1,022,265 | $1.9M | New |
| GRCE Grace Therapeutics Inc. | 0.10% | 772,900 | $1.8M | Add +2.1% |
| AVR Anteris Technologies Global | 0.09% | 166,229 | $1.6M | Reduce -58.6% |
| VIR Vir Biotechnology Inc. | 0.09% | 156,636 | $1.6M | Reduce -37.4% |
| EDIT Editas Medicine Inc. | 0.08% | 458,809 | $1.5M | Add +57.7% |
| WHWK Whitehawk Therapeutics Inc. | 0.08% | 303,306 | $1.4M | Reduce -1.1% |
| TECH Bio-Techne Corp. | 0.07% | 19,308 | $1.4M | Reduce -84.7% |
| RVMD Revolution Medicines Inc. | 0.07% | 6,943 | $1.3M | New |
| SVRA Savara Inc. | 0.07% | 204,428 | $1.3M | Reduce -46.8% |
| SRZN Surrozen Inc. | 0.07% | 47,777 | $1.2M | Reduce -18.5% |
| INO Inovio Pharmaceuticals Inc. | 0.06% | 1,035,360 | $1.1M | No change |
| PLRX Pliant Therapeutics Inc. | 0.06% | 891,425 | $1.0M | No change |
| HELP Cybin Inc. | 0.05% | 146,403 | $968K | New |
| ODTX Odyssey Therapeutics Inc. | 0.05% | 49,658 | $929K | New |
| ENGN Engene Therapeutics Inc. | 0.04% | 469,584 | $812K | Reduce -8.0% |
| BCYC Bicycle Therapeutics PLC-ADR | 0.04% | 190,715 | $809K | No change |
| LPCN Lipocine Inc. | 0.04% | 294,989 | $755K | No change |
| RLMD Relmada Therapeutics Inc. | 0.04% | 93,192 | $645K | Reduce -66.5% |
| EHTH Ehealth Inc. | 0.03% | 404,854 | $603K | Add +83.3% |
| ATAI Ataibeckley Inc. | 0.03% | 102,430 | $540K | New |
| AKBA Akebia Therapeutics Inc. | 0.03% | 427,095 | $487K | New |
| SSII SS Innovations International | 0.02% | 110,157 | $457K | No change |
| ASMB Assembly Biosciences Inc. | 0.02% | 16,510 | $454K | Reduce -59.6% |
| RVP Retractable Technologies Inc. | 0.02% | 580,919 | $418K | No change |
| SLQT Selectquote Inc. | 0.01% | 319,788 | $269K | Reduce -10.6% |
| GHRS GH Research PLC | 0.01% | 8,672 | $233K | New |
| AVTX Avalo Therapeutics Inc. | 0.01% | 10,000 | $185K | New |
Options reported separately and not counted above: QQQ puts ($72.6M), INSM calls ($10.3M), XBI puts ($4.9M), UHS puts ($2.8M), QGEN calls ($2.7M).
Portfolio Sells Q1 2026 → Q2 2026
| GSK GSK PLC-Spon ADR | Reduce -73.0% | 1.38% | −5.12 |
| NTRA Natera Inc. | Reduce -54.3% | 2.60% | −2.47 |
| DOC Healthpeak Properties Inc. | Sold out | 0.00% | −2.15 |
| PCVX Vaxcyte Inc. | Reduce -31.8% | 2.00% | −1.54 |
| AVTR Avantor Inc. | Sold out | 0.00% | −1.54 |
| QGEN Qiagen N.V. | Sold out | 0.00% | −1.44 |
| WELL Welltower Inc. | Reduce -51.8% | 1.08% | −1.28 |
| SNDX Syndax Pharmaceuticals Inc. | Reduce -3.0% | 3.33% | −1.11 |
| BCRX Biocryst Pharmaceuticals Inc. | Reduce -38.6% | 1.02% | −0.89 |
| RGEN Repligen Corp. | Reduce -88.1% | 0.11% | −0.83 |
| ARQT Arcutis Biotherapeutics Inc. | Reduce -76.5% | 0.19% | −0.70 |
| GERN Geron Corp. | Reduce -0.6% | 1.31% | −0.54 |
| ICLR Icon PLC | Sold out | 0.00% | −0.50 |
| AGIO Agios Pharmaceuticals Inc. | Sold out | 0.00% | −0.45 |
| OHI Omega Healthcare Investors | Reduce -17.4% | 1.26% | −0.43 |
| ARDX Ardelyx Inc. | Reduce -24.7% | 0.47% | −0.41 |
| TECH Bio-Techne Corp. | Reduce -84.7% | 0.07% | −0.36 |
| MDGL Madrigal Pharmaceuticals Inc. | Sold out | 0.00% | −0.34 |
| ESPR Esperion Therapeutics Inc. | Sold out | 0.00% | −0.31 |
| HQY Healthequity Inc. | Sold out | 0.00% | −0.28 |
| DAWN Day One Biopharmaceuticals I | Sold out | 0.00% | −0.26 |
| CYH Community Health Systems Inc. | Reduce -9.4% | 1.43% | −0.25 |
| CNC Centene Corp. | Sold out | 0.00% | −0.24 |
| BKD Brookdale Senior Living Inc. | Reduce -4.8% | 2.98% | −0.24 |
| ABVX Abivax SA-ADR | Reduce -2.2% | 6.64% | −0.22 |
| EHAB Enhabit Inc. | Sold out | 0.00% | −0.21 |
| GKOS Glaukos Corp. | Reduce -51.3% | 0.22% | −0.20 |
| ENGN Engene Therapeutics Inc. | Reduce -8.0% | 0.04% | −0.18 |
| ISRG Intuitive Surgical Inc. | Reduce -34.9% | 0.16% | −0.18 |
| STRO Sutro Biopharma Inc. | Sold out | 0.00% | −0.12 |
| CLDX Celldex Therapeutics Inc. | Reduce -0.1% | 3.62% | −0.11 |
| PALI Palisade Bio Inc. | Reduce -16.1% | 0.48% | −0.10 |
| NVCR Novocure Ltd. | Sold out | 0.00% | −0.10 |
| BVS Bioventus Inc. Class A | Sold out | 0.00% | −0.10 |
| NAMS Newamsterdam Pharma Co. NV | Reduce -3.6% | 0.51% | −0.09 |
| RLMD Relmada Therapeutics Inc. | Reduce -66.5% | 0.04% | −0.09 |
| IVVD Invivyd Inc. | Reduce -1.7% | 0.11% | −0.09 |
| IMCR Immunocore Holdings PLC-ADR | Sold out | 0.00% | −0.08 |
| SVRA Savara Inc. | Reduce -46.8% | 0.07% | −0.07 |
| TYRA Tyra Biosciences Inc. | Sold out | 0.00% | −0.07 |
| PASG Passage Bio Inc. | Sold out | 0.00% | −0.07 |
| DHC Diversified Healthcare Trust | Sold out | 0.00% | −0.07 |
| INMD Inmode Ltd. | Sold out | 0.00% | −0.06 |
| VIR Vir Biotechnology Inc. | Reduce -37.4% | 0.09% | −0.06 |
| AVR Anteris Technologies Global | Reduce -58.6% | 0.09% | −0.06 |
| PMVP PMV Pharmaceuticals Inc. | Reduce -19.5% | 0.14% | −0.05 |
| ASMB Assembly Biosciences Inc. | Reduce -59.6% | 0.02% | −0.05 |
| SRZN Surrozen Inc. | Reduce -18.5% | 0.07% | −0.04 |
| PHVS Pharvaris NV | Reduce -5.1% | 0.73% | −0.03 |
| AMRN Amarin Corp. PLC -ADR | Reduce -1.6% | 0.13% | −0.01 |
Portfolio Buys Q1 2026 → Q2 2026
| ENSG The Ensign Group Inc. | Add +3978.8% | 5.26% | +5.07 |
| EHC Encompass Health Corp. | Add +429.1% | 5.66% | +4.42 |
| CTRE Caretrust REIT Inc. | New | 2.36% | +2.36 |
| TVTX Travere Therapeutics Inc. | Add +47.3% | 2.47% | +1.41 |
| UNH Unitedhealth Group Inc. | New | 1.16% | +1.16 |
| COGT Cogent Biosciences Inc. | New | 1.03% | +1.03 |
| INSM Insmed Inc. | New | 0.87% | +0.87 |
| THC Tenet Healthcare Corp. | Add +287.0% | 1.16% | +0.80 |
| VKTX Viking Therapeutics Inc. | Add +152.2% | 1.28% | +0.77 |
| AMN Amn Healthcare Services Inc. | New | 0.76% | +0.76 |
| CELC Celcuity Inc. | New | 0.73% | +0.73 |
| MOH Molina Healthcare Inc. | Add +145.6% | 1.00% | +0.72 |
| HUM Humana Inc. | New | 0.68% | +0.68 |
| CRVS Corvus Pharmaceuticals Inc. | New | 0.61% | +0.61 |
| ASND Ascendis Pharma A/S | New | 0.61% | +0.61 |
| CHE Chemed Corp. | Add +69.1% | 1.33% | +0.56 |
| MLYS Mineralys Therapeutics Inc. | New | 0.46% | +0.46 |
| NVO Novo-Nordisk A/S-Spons ADR | New | 0.44% | +0.44 |
| BHVN Biohaven Ltd. | New | 0.42% | +0.42 |
| PTGX Protagonist Therapeutics Inc. | New | 0.39% | +0.39 |
| ELVN Enliven Therapeutics Inc. | New | 0.38% | +0.38 |
| DFTX Definium Therapeutics Inc. | Add +35.1% | 0.56% | +0.36 |
| BRKR Bruker Corp. | Add +56.3% | 0.60% | +0.32 |
| BEAM Beam Therapeutics Inc. | New | 0.31% | +0.31 |
| PNTG The Pennant Group Inc. | Add +47.4% | 0.93% | +0.30 |
| NHI Natl Health Investors Inc. | New | 0.29% | +0.29 |
| PACS Pacs Group Inc. | New | 0.27% | +0.27 |
| RLAY Relay Therapeutics Inc. | Add +60.4% | 0.44% | +0.27 |
| NHC National Healthcare Corp. | New | 0.25% | +0.25 |
| EYPT Eyepoint Inc. | New | 0.23% | +0.23 |
| RARE Ultragenyx Pharmaceutical Inc. | Add +146.3% | 0.28% | +0.19 |
| TARS Tarsus Pharmaceuticals Inc. | New | 0.19% | +0.19 |
| REPL Replimune Group Inc. | Add +76.3% | 0.36% | +0.19 |
| SNDA Sonida Senior Living Inc. | Add +260.9% | 0.23% | +0.17 |
| LLY Eli Lilly & Co. | Add +5.9% | 1.32% | +0.16 |
| LBRX LB Pharmaceuticals Inc. | Add +83.3% | 0.33% | +0.16 |
| ANAB Anaptysbio Inc. | Add +158.3% | 0.26% | +0.16 |
| VOR Vor Biopharma Inc. | New | 0.15% | +0.15 |
| XENE Xenon Pharmaceuticals Inc. | Add +51.7% | 0.65% | +0.15 |
| DSGN Design Therapeutics Inc. | New | 0.15% | +0.15 |
| GPCR Structure Therapeutics Inc. | Add +42.2% | 0.57% | +0.14 |
| SPRB Spruce Biosciences Inc. | New | 0.12% | +0.12 |
| PRQR Proqr Therapeutics NV | New | 0.10% | +0.10 |
| LTC LTC Properties Inc. | Add +31.0% | 0.88% | +0.10 |
| SPRY Ars Pharmaceuticals Inc. | Add +176.7% | 0.16% | +0.09 |
| RVMD Revolution Medicines Inc. | New | 0.07% | +0.07 |
| EQ Equillium Inc. | Add +1.5% | 0.27% | +0.07 |
| HELP Cybin Inc. | New | 0.05% | +0.05 |
| ODTX Odyssey Therapeutics Inc. | New | 0.05% | +0.05 |
| EVMN Evommune Inc. | Add +219.1% | 0.13% | +0.04 |
Options Activity Q1 2026 → Q2 2026
| QQQ Invesco QQQ Trust Series 1 | put | Reduce -58.7% | 98,600 | $72.6M |
| SPY SS SPDR S&P 500 ETF Trust-US | put | Sold out | 107,000 | $69.6Mbefore exit |
| VRTX Vertex Pharmaceuticals Inc. | call | Sold out | 90,000 | $40.2Mbefore exit |
| TLT iShares 20+ Year Treasury BD | put | Sold out | 428,800 | $37.2Mbefore exit |
| HYG Ishr Ibx Usd Hiyld CB ETF-Ui | put | Sold out | 180,000 | $14.3Mbefore exit |
| UNH Unitedhealth Group Inc. | call | Sold out | 40,000 | $10.8Mbefore exit |
| INSM Insmed Inc. | call | Add +2.8% | 96,600 | $10.3M |
| IWM iShares Russell 2000 ETF | put | Sold out | 40,000 | $9.9Mbefore exit |
| XLK SS Technology Select Sector | put | Sold out | 70,000 | $9.3Mbefore exit |
| XBI SS SPDR S&P Biotech ETF | put | Add +3.3% | 31,000 | $4.9M |
| PRAX Praxis Precision Medicines I | put | Sold out | 14,800 | $4.8Mbefore exit |
| XLE SS Energy Select Sector | call | Sold out | 50,000 | $3.1Mbefore exit |
| UHS Universal Health Services-B | put | Add +3.3% | 18,800 | $2.8M |
| QGEN Qiagen N.V. | call | Reduce -85.7% | 68,100 | $2.7M |
| REPL Replimune Group Inc. | call | Sold out | 52,000 | $398Kbefore exit |
| KPTI Karyopharm Therapeutics Inc. | call | Sold out | 23,800 | $133Kbefore exit |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 115 | $1.8B | UTHR, ABVX, EHC, ENSG, VERA |
| Q1 2026 | 104 | $1.5B | UTHR, ABVX, GSK, VERA, NTRA |
| Q4 2025 | 103 | $1.8B | VERA, GSK, UTHR, ABVX, NTRA |
| Q3 2025 | 83 | $1.3B | UTHR, GSK, NTRA, VERA, SNDX |
| Q2 2025 | 67 | $992.2M | NTRA, GSK, VERA, RVTY, PCVX |
| Q1 2025 | 55 | $883.7M | NTRA, GSK, HCA, SNDX, VERA |
| Q4 2024 | 62 | $969.1M | NTRA, GSK, VERA, INSP, HCA |
| Q3 2024 | 65 | $1.3B | GSK, NTRA, VERA, INSM, SNDX |
| Q2 2024 | 72 | $1.3B | GSK, NTRA, INSM, TEVA, UTHR |
| Q1 2024 | 68 | $1.3B | NTRA, GSK, INSP, TEVA, VERA |